Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes
Phase of Trial: Phase III
Latest Information Update: 26 May 2016
At a glance
- Drugs Linagliptin (Primary)
- Indications Arteriosclerosis; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms RELEASE
- 07 Jun 2017 Biomarkers information updated
- 17 May 2016 Status changed from active, no longer recruiting to completed.
- 28 Oct 2015 Planned End Date changed from 1 Sep 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.